These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Role of tetrabenazine for Huntington's disease-associated chorea. Poon LH; Kang GA; Lee AJ Ann Pharmacother; 2010 Jun; 44(6):1080-9. PubMed ID: 20442355 [TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease. Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540 [TBL] [Abstract][Full Text] [Related]
17. Tetrabenazine (Xenazine) for Huntington's chorea. Med Lett Drugs Ther; 2009 Jan; 51(1304):7-8. PubMed ID: 19172140 [No Abstract] [Full Text] [Related]
18. Rational approaches to the pharmacotherapy of chorea. Chase TN Res Publ Assoc Res Nerv Ment Dis; 1976; 55():337-50. PubMed ID: 137504 [No Abstract] [Full Text] [Related]
19. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea. Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763 [No Abstract] [Full Text] [Related]
20. Huntington's chorea. Changes in neurotransmitter receptors in the brain. Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]